Company / Current Assets
AGIOS PHARMACEUTICALS, INC. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$942.1M
FY2025
5-year range
$832.8M / $1.1B
FY2021-FY2025
Trend
-2.4%
vs FY2024
Sector context
#56 of 213
Health Care
What the data says
At $942M, AGIOS PHARMACEUTICALS, INC.'s current assets ranks #56 of 213 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $445M in FY2017 to $1.1B in FY2021.
Based on SEC 10-K filings.
$942M in FY2025 with a 5-year CAGR of +8.2%.
Improved from $834M to $942M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +4.2%
- 5-Year CAGR
- +8.2%
- 10-Year CAGR
- -
Sector benchmark
#56 of 213 in Health CareTop 26% of 213This company $942.1M Sector average $2.5B
▼
-62.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.2%, indicating consistent growth.
- In FY2025, current assets decreased 2.4% year-over-year.
- Ranks #56 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $942.1M | -2.4% |
| FY2024 | $965.6M | +15.8% |
| FY2023 | $833.8M | +0.1% |
| FY2022 | $832.8M | -21.7% |
| FY2021 | $1.1B | +67.2% |
| FY2020 | $636.7M | +4.1% |
| FY2019 | $611.7M | -0.3% |
| FY2018 | $613.8M | +37.8% |
| FY2017 | $445.3M | -20.5% |
| FY2016 | $559.9M | +66.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026